Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Shares Outstanding (Weighted Average): 2010-2024

Historic Shares Outstanding (Weighted Average) for OptimizeRx (OPRX) over the last 13 years, with FY2024 value amounting to $18.3 million.

  • OptimizeRx's Shares Outstanding (Weighted Average) rose 137.89% to $18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.6 million, marking a year-over-year increase of 137.89%. This contributed to the annual value of $18.3 million for FY2024, which is 682.13% up from last year.
  • According to the latest figures from FY2024, OptimizeRx's Shares Outstanding (Weighted Average) is $18.3 million, which was up 682.13% from $17.1 million recorded in FY2023.
  • In the past 5 years, OptimizeRx's Shares Outstanding (Weighted Average) ranged from a high of $18.3 million in FY2024 and a low of $14.8 million during FY2020
  • Over the past 5 years, OptimizeRx's median Shares Outstanding (Weighted Average) value was $17.2 million (recorded in 2021), while the average stood at $17.1 million.
  • Per our database at Business Quant, OptimizeRx's Shares Outstanding (Weighted Average) surged by 1618.63% in 2021 and then crashed by 370.67% in 2023.
  • Over the past 5 years, OptimizeRx's Shares Outstanding (Weighted Average) (Annual) stood at $14.8 million in 2020, then rose by 16.19% to $17.2 million in 2021, then grew by 3.23% to $17.8 million in 2022, then dropped by 3.71% to $17.1 million in 2023, then rose by 6.82% to $18.3 million in 2024.
  • Its Shares Outstanding (Weighted Average) stands at $18.3 million for FY2024, versus $17.1 million for FY2023 and $17.8 million for FY2022.